PMID: 11922947Mar 30, 2002Paper

Prediction of 'drug-likeness'

Advanced Drug Delivery Reviews
W P Walters, M A Murcko

Abstract

Recent developments in combinatorial chemistry and high-throughput screening have dramatically increased the scale on which drug discovery programs are carried out. Along with these advances has come a need for automated methods of determining which compounds from a library should be synthesized and screened. These methods range from simple counting schemes to sophisticated machine learning techniques such as neural networks. While many of these methods have performed well in validation studies, the field is still in its formative stage. This paper reviews a number of computational techniques for identifying drug-like molecules and examines challenges facing the field.

References

Dec 1, 1984·Journal of Medicinal Chemistry·P R AndrewsJ L Martin
Jul 19, 1996·Journal of Medicinal Chemistry·G W Bemis, M A Murcko
Nov 22, 1996·Journal of Medicinal Chemistry·F LombardoW J Curatolo
Feb 1, 1997·Journal of Molecular Graphics & Modelling·X Q Lewell, R Smith
Apr 16, 1998·Journal of Chemical Information and Computer Sciences·V J GilletJ Bradshaw
Aug 28, 1998·Journal of Medicinal Chemistry·A AjayM A Murcko
Aug 28, 1998·Journal of Medicinal Chemistry·J Sadowski, H Kubinyi
Jul 27, 1999·Current Opinion in Chemical Biology·W P WaltersM A Murcko
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·I D KuntzP A Kollman
Oct 26, 1999·Journal of Chemical Information and Computer Sciences·M HannN Ramsden
Dec 10, 1999·Journal of Medicinal Chemistry· AjayM A Murcko
Dec 22, 1999·Journal of Medicinal Chemistry·G W Bemis, M A Murcko
Dec 30, 1999·Journal of Chemical Information and Computer Sciences·A R LeachJ J Delany
Dec 30, 1999·Journal of Chemical Information and Computer Sciences·J WangY Tang
Feb 1, 2000·Drug Discovery Today·D E Clark, S D Pickett
Feb 19, 2000·Current Opinion in Biotechnology·J F Blake
Apr 13, 2000·Journal of Chemical Information and Computer Sciences·S D PickettD E Clark
Apr 13, 2000·Journal of Chemical Information and Computer Sciences·M Wagener, van Geerestein VJ
Oct 25, 2000·Journal of Chemical Information and Computer Sciences·J Xu, J Stevenson
Dec 29, 2000·Journal of Chemical Information and Computer Sciences·T M FrimurerS Brunak
Jan 6, 2001·Journal of Molecular Graphics & Modelling·R D BrownM Waldman
Jan 6, 2001·Journal of Molecular Graphics & Modelling·S ShiA Kuki
Mar 29, 2001·Journal of Pharmacological and Toxicological Methods·C A Lipinski
Jun 1, 2001·Journal of Medicinal Chemistry·I MueggeD Brittelli
Jun 21, 2001·Journal of Chemical Information and Computer Sciences·M M HannG Harper
Oct 18, 2001·Journal of Chemical Information and Computer Sciences·T I OpreaP D Leeson

❮ Previous
Next ❯

Citations

Mar 28, 2008·Journal of Computer-aided Molecular Design·Rajni Garg, Barun Bhhatarai
Oct 12, 2012·Journal of Computer-aided Molecular Design·Peter Ertl, Richard Lewis
Apr 15, 2004·International Journal of Pharmaceutics·Stefan Balbach, Christian Korn
Aug 27, 2013·Neuropharmacology·Trine KvistHans Bräuner-Osborne
Feb 6, 2004·Seminars in Cancer Biology·Ruiwu LiuKit S Lam
Jan 28, 2003·Drug Discovery Today·Paul D Lyne
Dec 4, 2012·Journal of Chemical Information and Modeling·Jonathan B Baell
Jul 16, 2011·Journal of Medicinal Chemistry·W Patrick WaltersMark A Murcko
Dec 17, 2004·Nature·Christopher Lipinski, Andrew Hopkins
Jun 23, 2010·Molecular BioSystems·Sean EkinsBarry A Bunin
Apr 20, 2004·Assay and Drug Development Technologies·Tao Guo, Doug W Hobbs
Dec 24, 2011·Assay and Drug Development Technologies·Eliza J R PetersonScott F Singleton
Feb 17, 2005·Bioinformatics·Svava Osk JónsdóttirSøren Brunak
May 23, 2012·Experimental Diabetes Research·Francis S WillardKyle W Sloop
May 17, 2011·BMC Bioinformatics·Kailin TangZhiwei Cao
Aug 2, 2012·Journal of Cheminformatics·Hans-Christian Ehrlich, Matthias Rarey
Jul 8, 2009·International Journal of Molecular Sciences·Pablo R Duchowicz, Eduardo A Castro
Mar 24, 2011·Future Medicinal Chemistry·Jonathan B Baell
Dec 24, 2013·Journal of Pharmacological and Toxicological Methods·Sean Ekins
Jan 19, 2012·Journal of Computer-aided Molecular Design·G SeddonG Vriend
Nov 5, 2014·BMC Complementary and Alternative Medicine·Haixing YangYonghua Wang
Jan 31, 2015·International Journal of Molecular Sciences·Jingxiao ZhangLing Yang
Mar 18, 2010·Expert Opinion on Drug Metabolism & Toxicology·Hua GaoJing Lin
Dec 15, 2015·Virology·Mariangela AgamennoneFabiana Superti
Apr 2, 2015·Chemical Communications : Chem Comm·Tiago RodriguesGisbert Schneider
Feb 10, 2016·Journal of Chemical Information and Modeling·Thomas Böttcher
Feb 14, 2013·Drug Discovery Today·Karen T SchomburgMatthias Rarey
Mar 1, 2012·Neurochemistry International·Ravichandran SrividhyaPeriandavan Kalaiselvi
Feb 11, 2015·Advanced Drug Delivery Reviews·Sheng TianTingjun Hou
Aug 2, 2015·Journal of Ethnopharmacology·Yan LiYonghua Wang
Oct 17, 2013·The Journal of Organic Chemistry·Sunkyu HanMohammad Movassaghi
Oct 28, 2015·Journal of Medicinal Chemistry·Jonathan BissonGuido F Pauli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.